Celebrex In Acute Gouty Arthritis Study
Public ClinicalTrials.gov record NCT00549549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Efficacy And Safety Of Celecoxib (Celebrex®) And Indomethacin In The Treatment Of Moderate To Severe Acute Gouty Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, double-blind, double-dummy, randomized, active-controlled study that will include an 8-day treatment period followed by a 1-week follow-up period in patients experiencing symptoms of an acute exacerbation of gouty arthritis.
Study identification
- NCT ID
- NCT00549549
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 402 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Dec 2009 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- Feb 21, 2021
2008 – 2009
United States locations
- U.S. sites
- 43
- U.S. states
- 21
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Glendale | Arizona | 85304 | — |
| Pfizer Investigational Site | Mesa | Arizona | 85202 | — |
| Pfizer Investigational Site | Paradise Valley | Arizona | 85253 | — |
| Pfizer Investigational Site | Peoria | Arizona | 85381 | — |
| Pfizer Investigational Site | Roseville | California | 95661 | — |
| Pfizer Investigational Site | San Diego | California | 92103-6204 | — |
| Pfizer Investigational Site | San Luis Obispo | California | 93405 | — |
| Pfizer Investigational Site | Longmont | Colorado | 80501 | — |
| Pfizer Investigational Site | Northglenn | Colorado | 80234 | — |
| Pfizer Investigational Site | DeLand | Florida | 32720 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32607 | — |
| Pfizer Investigational Site | Tampa | Florida | 33606 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Dunwoody | Georgia | 30338 | — |
| Pfizer Investigational Site | Rockford | Illinois | 61107 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40504 | — |
| Pfizer Investigational Site | Mount Sterling | Kentucky | 40353 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71105-5634 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71106 | — |
| Pfizer Investigational Site | Wheaton | Maryland | 20902 | — |
| Pfizer Investigational Site | Lansing | Michigan | 48910-8595 | — |
| Pfizer Investigational Site | Chaska | Minnesota | 55318 | — |
| Pfizer Investigational Site | Columbia | Missouri | 65203 | — |
| Pfizer Investigational Site | Columbus | Missouri | 65212 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63141 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68134 | — |
| Pfizer Investigational Site | Mineola | New York | 11501 | — |
| Pfizer Investigational Site | Statesville | North Carolina | 28625 | — |
| Pfizer Investigational Site | Lyndhurst | Ohio | 44124 | — |
| Pfizer Investigational Site | Willoughby Hills | Ohio | 44094 | — |
| Pfizer Investigational Site | Duncansville | Pennsylvania | 16635 | — |
| Pfizer Investigational Site | Havertown | Pennsylvania | 19083 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | — |
| Pfizer Investigational Site | New Tazewell | Tennessee | 37825 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77701 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77706 | — |
| Pfizer Investigational Site | Bryan | Texas | 77802 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78217 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78224 | — |
| Pfizer Investigational Site | Tyler | Texas | 75701 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53295 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00549549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00549549 live on ClinicalTrials.gov.